Haller et al. demonstrated that irinotecan plus oxaliplatin (IROX) is more efficacious than irinotecan alone after fluoropyrimidine failure in advanced colorectal cancer. IROX does not change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback